Product Information
REPAGLINIDE 1 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0887 per EA under NDC 57237015801. Its NADAC has been published 506 times since Oct 19, 2016.
Strength
1 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237015801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
REPAGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203820On Market Since
1/22/2014
Pharmacological Classes
Price Statistics
The NADAC for REPAGLINIDE 1 MG TABLET has been published 506 times since Oct 19, 2016, and over the history we have for it it has declined 66.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0887 per EA |
|---|---|
| All-time high | $0.2813 (Dec 14, 2016) |
| All-time low | $0.0800 (Mar 18, 2026) |
| 52-week high | $0.1201 |
| 52-week low | $0.0800 |
| Median price | $0.1545 |
| Average price | $0.1566 |
| Largest weekly change | +37.7% (Nov 18, 2020) |
| Weeks tracked | 506 |
| Tracking since | Oct 19, 2016 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of REPAGLINIDE 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for REPAGLINIDE 1 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0887 per EA (NDC 57237015801), effective Jun 24, 2026.
How has the price of REPAGLINIDE 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for REPAGLINIDE 1 MG TABLET has declined 66.2%. It has been tracked across 506 weekly CMS publications since Oct 19, 2016.
What are the highest and lowest recorded NADAC prices for REPAGLINIDE 1 MG TABLET?
Since Oct 19, 2016, the NADAC for REPAGLINIDE 1 MG TABLET has ranged from a low of $0.0800 (Mar 18, 2026) to a high of $0.2813 (Dec 14, 2016), with a median of $0.1545 per EA.
Are there cheaper alternatives to REPAGLINIDE 1 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as REPAGLINIDE 1 MG TABLET, but none are currently priced below it.
Who manufactures REPAGLINIDE 1 MG TABLET?
REPAGLINIDE 1 MG TABLET (NDC 57237015801) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification